Microlin Bio

Microlin Bio, Inc., a development stage biopharmaceutical company

Microlin Bio, Inc., a development stage biopharmaceutical company, focuses on identifying and developing pharmaceutical and diagnostic products for the diagnosis and treatment of cancer. It intends to develop a series of diagnostic microRNA panel tests, and miR-based antimicroRNA therapy and microRNA-replacement therapy agents for lung, ovarian, colorectal, and prostate cancers. The company was founded in 2013 and is headquartered New York, New York.